Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery.
about
Particle-mediated delivery of cytokines for immunotherapyImmunosuppressive and anti-inflammatory properties of engineered nanomaterialsRemyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple SclerosisMicro and nanoparticle drug delivery systems for preventing allotransplant rejectionSynthetic Nanoparticles for Vaccines and ImmunotherapyModelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease.Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient miceAnalysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.Cell-Intrinsic gp130 Signaling on CD4+ T Cells Shapes Long-Lasting Antiviral ImmunityNeurological disorders and therapeutics targeted to surmount the blood-brain barrierHarnessing nanoparticles for immune modulationBiomaterial Strategies for Immunomodulation.Biotargeted nanomedicines for cancer: six tenets before you beginEngineering nanomaterials to address cell-mediated inflammation in atherosclerosis.Engineering nano- and microparticles to tune immunityEnhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugatesPolymer delivery systems for site-specific genome editingRejection and regulation: a tight balance.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Applications of nanotechnology for immunology.Strategies to direct the enrichment, expansion, and recruitment of regulatory cells for the treatment of disease.Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance.Selective uptake of cylindrical poly(2-oxazoline) brush-antiDEC205 antibody-OVA antigen conjugates into DEC-positive dendritic cells and subsequent T-cell activation.Targeting T cell metabolism for therapy.Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis.Paracrine co-delivery of TGF-β and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells.Regulatory T cell-based therapies for autoimmunity.Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)An in silico analysis of nanoparticle/cell diffusive transfer: application to nano-artificial antigen-presenting cell:T-cell interaction.Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-Therapy.T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity.Polymeric Biomaterials: Diverse Functions Enabled by Advances in Macromolecular Chemistry.Leukemia Inhibitory Factor-Loaded Nanoparticles with Enhanced Cytokine Metabolic Stability and Anti-Inflammatory Activity.Stem cell therapy versus T lymphocytes: friend or foe?Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer.Treg cells as potential cellular targets for functionalized nanoparticles in cancer therapy.Regulation of T-Cell Signaling by Post-Translational Modifications in Autoimmune Disease.Ex Vivo Induced Regulatory Human/Murine Mesenchymal Stem Cells as Immune Modulators.
P2860
Q26997993-4253F001-1C46-481A-BB0C-7C450F38C7BCQ27005267-0B1C7FC0-281D-40DA-B5AA-6019AB9E96E6Q27339236-019B1BBC-20F4-4E74-A3B9-57EEB5D0D136Q28080720-1C754EE9-CA2D-4655-BE69-9A1643CF1AFAQ28085375-8BC3131F-5910-473D-B379-F69C252E53ADQ34241152-0DCB955A-44B8-482C-99A6-06DC64D247D9Q34506953-9FBA9284-0067-46AD-8C11-2EF67C75A896Q34675068-B99DD96A-5E1A-4C78-B8D0-19D9DE6D5ADDQ35625854-E98BC5D2-C5B0-4EC6-A4C8-56066FBC1C4DQ35864505-57E2ECA8-59A1-4671-8BA6-CC29F13E8893Q36119574-57056DFF-1CFD-4266-BED9-4E5449A23AC6Q36154772-46A4A85A-2709-468A-8A14-6D97BD1D275AQ36703124-C2F17B4D-5DD0-4610-985F-93602F0049F0Q36814280-C687B5D8-A8B0-4923-A436-F86C2846AACDQ36848196-B206FEB0-C018-4D3B-9EA7-D5E1710082EAQ37205125-2205D4D1-8CA0-4330-91D0-53F2CCD5E185Q37238542-2859A247-0262-4D16-8A3B-7879392DEB20Q37881210-37228659-D1BD-40DA-B8AA-D214D72071E1Q37966922-B8628208-9F42-4204-973B-8FA1D3D896F9Q38067265-4AF929BE-427F-44F9-8887-489C8FB0EDD6Q38123937-F1311293-DBD6-4334-A89D-3648DD753CD6Q38253203-E18C6435-CECB-47C1-A38B-E4D90386E1FBQ38297557-39D6D734-106E-4F50-9696-94EEB216B806Q38305108-31F5D2AB-6372-4374-8988-B16DF57C32F6Q38324388-8F22ABB9-3789-4F91-B6AA-3C3B65EECC74Q38418305-BB2662B1-300E-4D17-BD5F-62D4F124C69DQ38534740-93A0D3D2-B2EE-403F-89B7-EA1716DB03B9Q38874906-40DB5590-ED51-457C-9973-3590D878532BQ38943933-CCD15ECB-28C7-4134-AE96-B5D87F24E22DQ40617937-3850C94A-EAEC-47AF-9485-EC9A297CC374Q41477320-12D80D32-F9F7-435B-AA49-CDB84299F37BQ42065629-806F0243-FED6-46F6-A898-CD5B3455AE14Q47132997-58112BA2-0A23-48B6-AE0E-C7F8F5AA1A4EQ47335627-B7D7B966-1074-4E13-9150-7C67C9C78E24Q47755745-7304B980-701F-46FC-A0EC-48BE75E6245CQ48490621-892F729B-0E29-413C-B081-7984041A246FQ49787181-25F84B70-129A-4F81-9EC2-E4CC3E87A751Q51799863-E67EFC9D-38DB-4BBC-A2E5-12A0C48A55B1Q52689527-B0B18353-5C4E-421F-88C3-683989E2C34FQ53554451-1B5E166E-3CC5-40F2-A946-EC0A5B1BCFEE
P2860
Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Modulation of CD4+ T lymphocyt ...... le-mediated cytokine delivery.
@en
Modulation of CD4+ T lymphocyt ...... le-mediated cytokine delivery.
@nl
type
label
Modulation of CD4+ T lymphocyt ...... le-mediated cytokine delivery.
@en
Modulation of CD4+ T lymphocyt ...... le-mediated cytokine delivery.
@nl
prefLabel
Modulation of CD4+ T lymphocyt ...... le-mediated cytokine delivery.
@en
Modulation of CD4+ T lymphocyt ...... le-mediated cytokine delivery.
@nl
P2093
P2860
P356
P1476
Modulation of CD4+ T lymphocyt ...... le-mediated cytokine delivery.
@en
P2093
Jason Park
Roy Whiston
Su Metcalfe
Tarek M Fahmy
Terry B Strom
P2860
P304
P356
10.1021/MP100203A
P407
P577
2010-12-08T00:00:00Z